COVID-19 Vaccines in IBD Patients: Particularities and Future Perspectives

Unidades de investigação
Abstract
[No abstract available]
Dados da publicação
- ISSN/ISSNe:
- 1873-9946, 1876-4479
- Tipo:
- Editorial Material
- Páginas:
- 1343-1344
- Link para outro recurso:
- www.scopus.com
JOURNAL OF CROHNS & COLITIS Oxford University Press
Documentos
- Não há documentos
Filiações
Filiações não disponíveis
Keywords
- COVID-19; COVID-19 Vaccines; Humans; Inflammatory Bowel Diseases; SARS-CoV-2; Tumor Necrosis Factor Inhibitors; Vaccination; ad26.cov2 s; ibacovavec; immunoglobulin G; infliximab; mercaptopurine; mesalazine; methotrexate; SARS-CoV-2 vaccine; tozinameran; ustekinumab; vaxzevria; vedolizumab; tumor necrosis factor inhibitor; antibody response; cellular immunity; coronavirus disease 2019; disease activity; Editorial; human; humoral immunity; immune response; immunoglobulin blood level; inflammatory bowel disease; monotherapy; adverse event; epidemiology; inflammatory bowel disease; prevention and control; vaccination
Proyectos asociados
Gut microbiome and IBD therapy: an interplay?
Investigador Principal: Fernando José Magro Dias
Estudo Observacional Académico (GutIBD) . 2021
Iron deficiency and inflammatory bowel disease. Correlation with inflammation and Vitamin D status.
Investigador Principal: Fernando José Magro Dias
Estudo Observacional Académico (IronIBD) . 2021
Looking 4WARD: The role of dipeptidyl peptidase 4 (DPP-4) in inflammatory bowel disease (IBD) as a novel biomarker for predicting disease activity and monitoring response to therapy in IBD patients.
Investigador Principal: Fernando José Magro Dias
Estudo Observacional Académico (4WARD) . 2021
Isolated Ulceration of Crohn’s Anastomosis
Investigador Principal: Fernando José Magro Dias
Estudo Clínico Académico . 2021
Therapeutic Drug Monitoring: An Emergent Approach in Inflammatory Bowel Disease
Investigador Principal: Fernando José Magro Dias
Estudo Clínico Académico . 2021
Contributo da endoscopia, biomarcadores e imagiologia na evolução clinica dos doentes com doença inflamatória intestinal
Investigador Principal: Fernando José Magro Dias
Estudo Clínico Académico . 2019
Citar a publicação
Magro F,Estevinho MM. COVID-19 Vaccines in IBD Patients: Particularities and Future Perspectives. J. Crohn's Colitis. 2022. 16(9):p. 1343-1344. IF:8,000. (1).